4598 Delta-Fly Pharma,Inc.Delta-Fly PharmaTSE Growth / Pharmaceuticals
0 posts
Delta-Fly Pharma,Inc. stock plunged on Nov 20: what happened
It closed at ¥60.0 on Nov 20 (−¥14.0, −18.92%), ranking #4 among the top losers of all stocks on the Tokyo Stock Exchange.
Disclosures around that day
Changes are calculated from the closing prices this site collects daily; limit-up/down is an estimate based on the daily price limit. Please make your own investment decisions.
Delta-Fly Pharma,Inc. (4598) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Delta-Fly Pharma,Inc. (4598) Stock Price HistoryNear an all-time low
Delta-Fly Pharma,Inc. closed at ¥60.0 on Nov 20, 2026, −24.1% over 1 month, −89.2% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥75,949 today (−24.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −24.1%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥60.0 | −14 | −18.92% |
| Nov 19 (Thu) | ¥74.0 | +16 | +27.59% |
| Nov 18 (Wed) | ¥58.0 | +0 | +0.00% |
| Nov 17 (Tue) | ¥58.0 | +1 | +1.75% |
| Nov 16 (Mon) | ¥57.0 | −5 | −8.06% |
| Nov 13 (Fri) | ¥62.0 | +2 | +3.33% |
| Nov 12 (Thu) | ¥60.0 | −4 | −6.25% |
| Nov 11 (Wed) | ¥64.0 | +1 | +1.59% |
| Nov 10 (Tue) | ¥63.0 | +3 | +5.00% |
| Nov 9 (Mon) | ¥60.0 | +1 | +1.69% |
If you had invested ¥100,000 3 months ago, it would be worth ¥56,075 today (−43.9%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −43.9%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥60.0 | −14 | −18.92% |
| Nov 19 (Thu) | ¥74.0 | +16 | +27.59% |
| Nov 18 (Wed) | ¥58.0 | +0 | +0.00% |
| Nov 17 (Tue) | ¥58.0 | +1 | +1.75% |
| Nov 16 (Mon) | ¥57.0 | −5 | −8.06% |
| Nov 13 (Fri) | ¥62.0 | +2 | +3.33% |
| Nov 12 (Thu) | ¥60.0 | −4 | −6.25% |
| Nov 11 (Wed) | ¥64.0 | +1 | +1.59% |
| Nov 10 (Tue) | ¥63.0 | +3 | +5.00% |
| Nov 9 (Mon) | ¥60.0 | +1 | +1.69% |
If you had invested ¥100,000 6 months ago, it would be worth ¥36,810 today (−63.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −63.2%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥60.0 | −13.0% |
| Oct 2026 | ¥69.0 | −40.5% |
| Sep 2026 | ¥116 | +11.5% |
| Aug 2026 | ¥104 | +2.0% |
| Jul 2026 | ¥102 | −20.9% |
| Jun 2026 | ¥129 | −18.9% |
| May 2026 | ¥159 | −18.0% |
If you had invested ¥100,000 1 year ago, it would be worth ¥10,811 today (−89.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −89.2%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥60.0 | −13.0% |
| Oct 2026 | ¥69.0 | −40.5% |
| Sep 2026 | ¥116 | +11.5% |
| Aug 2026 | ¥104 | +2.0% |
| Jul 2026 | ¥102 | −20.9% |
| Jun 2026 | ¥129 | −18.9% |
| May 2026 | ¥159 | −18.0% |
| Apr 2026 | ¥194 | −0.5% |
| Mar 2026 | ¥195 | −23.2% |
| Feb 2026 | ¥254 | +9.5% |
| Jan 2026 | ¥232 | −54.5% |
| Dec 2025 | ¥510 | −10.7% |
| Nov 2025 | ¥571 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥5,029 today (−95.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −95.0%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥60.0 | −88.2% |
| 2025 | ¥510 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥4,839 today (−95.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −95.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥60.0 | −88.2% |
| 2025 | ¥510 | ― |
If you had invested ¥100,000 in Oct 2018, it would be worth ¥1,179 today (−98.8%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +182.0%, while this stock moved −98.8%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥60.0 | −88.2% |
| 2025 | ¥510 | −10.1% |
| 2024 | ¥567 | −44.1% |
| 2023 | ¥1,015 | −20.2% |
| 2022 | ¥1,272 | −14.5% |
| 2021 | ¥1,487 | +24.4% |
| 2020 | ¥1,195 | −30.9% |
| 2019 | ¥1,729 | −36.5% |
| 2018 | ¥2,724 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Oct 2018). Please check the latest prices before trading.
Delta-Fly Pharma,Inc. (4598) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Delta-Fly Pharma,Inc. (4598)
Business overview
The company is a drug discovery firm whose corporate philosophy is to provide treatments that people can confidently recommend to family members with cancer by looking at the whole cancer patient rather than only the cancer. Developing a single drug generally takes about 10 to 15 years and several billion to tens of billions of yen, with a high risk of discontinuation at every stage, so making R&D more efficient and reducing risk are major challenges. Its drug discovery method is module-based drug discovery, which uses existing anticancer active substances and others as modules (building blocks) and assembles them with refinements to dosage, binding methods and more, creating new anticancer drugs with a better balance of clinical efficacy and safety. It is developing patient-friendly anticancer drugs for the world.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Market cap | ¥0.9 bn | No. 79 in the sector (largest first) |
|---|
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥659 | 2025/12/10 |
|---|---|---|
| 52-week low | ¥57 | 11/16 |
| Current position | 0.5% | Where the low is 0% and the high is 100% (close on 11/20: ¥60) |
| Year to date | -88.2% | No. 77 of 77 in the sector (best first) |
| 1 year | -89.2% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 1 times | Latest: 11/19 (No. 6) |
|---|---|---|
| Top 50 losers | 3 times | Latest: 11/20 (No. 4) |
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/19 15:40第三者割当により発行された第12回新株予約権(行使価額修正条項付)の大量行使に関するお知らせ
- 11/18 15:30DFP-10917の長期安定製剤の特許査定に関するお知らせ
- 11/13 15:352027年3月期第2四半期(中間期)決算短信〔日本基準〕(非連結)
- 11/13 15:352027年3月期第2四半期決算補足説明資料
- 11/05 15:30ASH 2026におけるDFP-10917の臨床試験2演題の発表採択に関するお知らせ
- 11/02 15:30第三者割当により発行された第12回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ
- 10/01 15:30第三者割当により発行された第12回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ
- 09/09 16:00第三者割当により発行された第12回新株予約権(行使価額修正条項付)の大量行使に関するお知らせ
Filings from the past 12 months (8).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Delta-Fly Pharma,Inc. board
More Japanese stocks in English
- StemRIM Inc.4599
- Nomura High-yield J-REIT Index ETF459A
- BRANU Inc.460A
- Dai Nippon Toryo Company,Limited4611
- NIPPON PAINT HOLDINGS CO.,LTD.4612
- KANSAI PAINT CO.,LTD.4613
- SHINTO PAINT COMPANY,LIMITED4615
- KAWAKAMI PAINT MANUFACTURING CO.,LTD.4616
- Chugoku Marine Paints,Ltd.4617
- Nihon Tokushu Toryo Co.,Ltd.4619
- MAXIS Japan Equity High Dividend SMART 50 ETF461A
- FUJIKURA KASEI CO.,LTD.4620